EPIC-321

N/A

Report date: 2026/05/11 20:01:57

Base Information

Drug NameEPIC-321
Drug Alias NameEPI-321EPIC-321
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAVrh74 vector
Mechanisms of ActionDouble Homeobox 4 Like 1 inhibitors
TargetsDouble Homeobox 4 Like 1
Therapy Area/IndicationsMuscular Dystrophy, Facioscapulohumeral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEpicrispr Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesEpicrispr Biotechnologies Inc
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Facioscapulohumeral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A